David Bloom, PhD, at University of Florida, FRAXA research grant

Studies on FMR1 Gene Delivery Using Herpes Simplex Virus Vectors

With $89,000 from FRAXA Research Foundation over 2001-2005, Dr. David Bloom investigated gene therapy for fragile X. The Bloom lab specializes in the development of gene therapy techniques, and they have succeeded in transferring the fragile X gene (fmr1) into the brains of live mice, using viral vectors. They studied ways to enhance this process, with the ultimate goal of gene therapy for people with fragile X.